Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHBG | P04278 | 6/20 | 1.00 |
| ▸ | CYP17A1 | P05093 | 5/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.70 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.70 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.70 |
| ▸ | G6PD | P11413 | 4/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.61 |
| ▸ | SERPINA6 | P08185 | 3/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | GUSB | P08236 | 1/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.61 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
| ▸ | ESR1 | P03372 | 1/20 | 0.58 |
| ▸ | AR | P10275 | 1/20 | 0.58 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17776491 | 1.00 | SHBG (1.00) | SHBGCYP17A1ALDH1A1CYP2C9HIF1A | |
| SCHEMBL138937 | 1.00 | SHBG (1.00) | SHBGCYP17A1ALDH1A1CYP2C9HIF1A | |
| SCHEMBL142941 | 1.00 | SHBG (1.00) | SHBGCYP17A1ALDH1A1CYP2C9HIF1A | |
| SCHEMBL27808104 | 1.00 | SHBG (1.00) | SHBGCYP17A1ALDH1A1CYP2C9HIF1A | |
| SCHEMBL658688 | 1.00 | SHBG (1.00) | SHBGCYP17A1ALDH1A1CYP2C9HIF1A | |
| SCHEMBL735471 | 1.00 | SHBG (1.00) | SHBGCYP17A1ALDH1A1CYP2C9HIF1A | |
| SCHEMBL18373712 | 1.00 | SHBG (1.00) | SHBGCYP17A1ALDH1A1CYP2C9HIF1A | |
| SCHEMBL20457510 | 1.00 | SHBG (1.00) | SHBGCYP17A1ALDH1A1CYP2C9HIF1A | |
| Sulfuric Acid SCHEMBL1576876 | 0.96 | SHBG (0.91) | SHBGCYP17A1ALDH1A1CYP2C9HIF1A | |
| SCHEMBL31086698 | 0.92 | SHBG (0.85) | SHBGCYP17A1ALDH1A1CYP2C9HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114460201-B | Diagnostic markers for distinguishing Ischemic Heart Disease (IHD) from Ischemic Heart Failure (IHF) | 北京市心肺血管疾病研究所 | 2023-04-28 | — | — | CN | disclosed |
| CN-105828836-A | Hendra and nipah virus g glycoprotein immunogenic compositions | 硕腾服务有限责任公司 | 2016-08-03 | — | — | CN | disclosed |
| CN-104619328-A | Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators | CORCEPT THERAPEUTICS INC | 2015-05-13 | — | — | CN | disclosed |
| CN-104244974-A | HENDRA AND NIPAH VIRUS G GLYCOPROTEIN IMMUNOGENIC COMPOSITIONS | AH USA 42 LLC | 2014-12-24 | — | — | CN | disclosed |
| CN-103298343-A | Combination steroid and glucocorticoid receptor antagonist therapy | CORCEPT THERAPEUTICS INC | 2013-09-11 | — | — | CN | disclosed |
| CN-101820917-B | Aqueous ophthalmic formulations | FOVEA PHARMACEUTICALS | 2013-01-02 | — | — | CN | disclosed |
| CN-101938996-A | Therapeutic regimens for the treatment of immunoinflammatory disorders | COMBINATORX INC | 2011-01-05 | — | — | CN | disclosed |
| CN-101820917-A | Aqueous ophthalmic formulations | FOVEA PHARMACEUTICALS SA | 2010-09-01 | — | — | CN | disclosed |
| CN-101678034-A | Method for treating neovascular ocular diseases | FOVEA PHARMACEUTICALS | 2010-03-24 | — | — | CN | disclosed |
| CN-101010083-A | Methods and reagents for the treatment of metabolic disorders | COMBINATORX INC (US) | 2007-08-01 | — | — | CN | disclosed |
| CN-1993051-A | Treatment regimens for combination administration | COMBINATORX INC (US) | 2007-07-04 | — | — | CN | disclosed |
| CN-1901863-A | Methods and medicaments for treating inflammatory diseases | COMBINATORX INC (US) | 2007-01-24 | — | — | CN | disclosed |
| CN-1889956-A | Methods and reagents for the treatment of immunoinflammatory disorders | COMBINATORX INC (US) | 2007-01-03 | — | — | CN | disclosed |
| CN-1700921-A | Methods and medicaments for treating diseases associated with elevated levels of proinflammatory cytokines | COMBINATORX INC (US) | 2005-11-23 | — | — | CN | disclosed |